A kinase inhibitor screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative breast cancer to EGFR-targeted therapy

Ronan P. McLaughlin(Leiden University), Bob van de Water(Leiden University)
Breast Cancer Research
July 1, 2019
Cited by 56


Related Papers